UnitedHealth and Humana Stocks Rebound Amid CMS Surprise

UNH and HUM surged Monday after the Centers for Medicare and Medicaid Services (CMS) finalized a 2.48% average payment rate increase for Medicare Advantage plans in 2027 — a figure significantly better than the 0.09% hike proposed in January and representing more than $13 billion in additional revenue for private insurers. UnitedHealth climbed as much as 9.6% intraday while Humana advanced up to 11%, with CVS Health also rising 6.9% on the news.

The announcement reverses what had been Wall Street's biggest near-term fear for managed care: that CMS would hold rates flat or cut them, squeezing margins at a time when the industry is already absorbing elevated medical costs from post-pandemic care demand and high-cost GLP-1 drugs. UnitedHealth Group operates one of the largest Medicare Advantage businesses in the US with roughly 7 million plan members, while Humana derives more than 90% of its revenue from government health programs, making the rate decision especially material to its earnings outlook.

Analysts noted that the rate improvement still falls short of what would fully offset medical cost inflation, but the direction of the CMS decision signals a more insurer-friendly posture from the Trump administration than the market had priced in. The key question for investors is whether higher rates translate to improved margins or simply fund continued benefit enhancements that keep premiums competitive for the 34 million seniors enrolled in Medicare Advantage nationally.